Log 10 Hiv-1 Rna

Here's a taste of what TheBody.com has to offer on this topic:
Ask the Experts

APTIMA HIV-1 RNA QUALITATIVE ASSAY (APTIMA - HIV-1 RNA QUALITATIVE ASSAY, 2010) Part 2

To the good Dr. Bob, I have submitted a donation on-line, and will submit a heftier holiday donation as well, but in the interim I was hoping you might field another inquiry from me regarding a post of mine a few weeks ago pertaining to the Aptima...
Robert J. Frascino, M.D.

Response from Robert J. Frascino, M.D.

The Robert James Frascino AIDS Foundation
Hi Aptimistaken,You're going to qualify for an advanced degree in nucleic acid polymerase chain reaction laboratory analysis before long. Dude, it's time to turn off your inner scientific geek and come back to planet earth. I can't believe you... Read more »

APTIMA HIV-1 RNA QUALITATIVE ASSAY (APTIMA - HIV-1 RNA QUALITATIVE ASSAY, 2010)

Dear Dr. Bob,I thank you kindly and sincerely for your efforts, support and the invaluable... Read more »

HIV-1 RNA Ultra

What does HIV-1 RNA Ultra mean or what does it measure. On 2/6/07 that number was 11809 and on... Read more »
Articles
The Body PRO

Abstract No. 383:Efficacy of Efavirenz (Sustiva) Concerning Regimens in Patients with Baseline Plasma HIV-1 RNA Viral Load Exceeding 100,000 copies/mL

Sustiva is a once-daily non-nucleoside reverse transcriptase inhibitor (NNRTI) which has demonstrated efficacy when used combination with either a protease inhibitor, NRTI or both in ARV naïve NRTI extreme patients. The antiretroviral activity of... Read more »
U.S. Centers for Disease Control and Prevention

The Effects of Early Syphilis on CD4 Counts and HIV-1 RNA Viral Loads in Blood and Semen

The researchers conducted a retrospective case-controlled study comparing blood plasma HIV-1 viral loads and CD4 counts in cases during early syphilis (n=63, 27 receiving antiretroviral therapy) to those before and after syphilis and with controls... Read more »
Tibotec Therapeutics

Prezista Now Available for Pediatric Patients Six Years of Age and Older as Part of HIV Combination Therapy

Bridgewater, NJ -- Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., today announced the availability of a lower-dose (75 mg) formulation of PREZISTA® (darunavir) for pediatric patients with HIV. The announcement... Read more »
The Body PRO

79% of Treatment-Experienced Patients on MK-0518 Plus OBT Achieve Viral Load of Less Than 400 Copies at Week 16

2007 has the potential to enter history books as the only year in which agents from two new HIV drug classes could receive U.S. Food and Drug Administration (FDA) approval for use in the treatment of HIV infection in the HIV treatment-experienced... Read more »
Related Topics